Suwon, South Korea

Jae-Gul Lee

This inventor holds 1 USPTO granted patent. Top assignee: Dong-A Pharm. Co., Ltd.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jae-Gul Lee. Retrieved from https://idiyas.com/inventor/jae-gul-lee-82m4dkk5

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 52(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jae-Gul Lee: Innovator in Antibacterial Compounds

Introduction

Jae-Gul Lee is a prominent inventor based in Suwon, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel antibacterial agents. His work focuses on creating compounds that exhibit superior antibacterial activity while maintaining low toxicity.

Latest Patents

Jae-Gul Lee holds a patent for "Oxazolidinone derivatives and a process for the preparation thereof." This invention relates to novel oxazolidinone derivatives, their pharmaceutically acceptable salts, and a process for their preparation. The compounds developed in this patent feature a pyridine or pyrimidine moiety substituted by heterocycles and heteroaromatic cycles at the 4-position of the phenyl ring. These compounds demonstrate a wide antibacterial spectrum, making them valuable as antibacterial agents.

Career Highlights

Jae-Gul Lee is associated with Dong-A Pharm. Co., Ltd., where he continues to innovate in the pharmaceutical industry. His work has led to advancements in antibacterial treatments, contributing to public health and safety.

Collaborations

Some of his notable coworkers include Dong-Goo Kim and Jong-Hwan Cho, who have collaborated with him on various projects within the company.

Conclusion

Jae-Gul Lee's contributions to the field of antibacterial compounds highlight his role as an influential inventor. His innovative work continues to impact the pharmaceutical industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…